Literature DB >> 17589930

Specific serum immunoglobulin G to H pylori and CagA in healthy children and adults (south-east of Iran).

A Jafarzadeh1, M-T Rezayati, M Nemati.   

Abstract

AIM: To evaluate the serologic IgG response to H pylori and CagA across age groups and in healthy children and adults.
METHODS: Totally, 386 children aged 1-15 years and 200 adults aged 20-60 years, were enrolled to study. The serum samples of participant were tested for presence of anti-H pylori and anti-CagA IgG by using ELISA method.
RESULTS: The seroprevalence of H pylori in adults was significantly higher than that observed in children (67.5% vs 46.6%; P < 0.000003). In children, the seropositivity rate in males (51.9%) was significantly (P < 0.05) higher than that observed in females (41.7%). The prevalence of serum anti-CagA antibody was 72.8% and 67.4% in infected children and adults, respectively. The mean titer of serum anti-CagA antibodies was significantly higher among children in comparison to adults (64.1 Uarb/mL vs 30.7; P < 0.03). In infected children and adults the prevalence of serum anti-CagA antibody was higher in males compared to females (78.4% vs 66.3%; P = 0.07 and 75.6% vs 54.71%; P < 0.04, respectively). The age-specific prevalence of anti-H pylori and anti-CagA antibody (in infected subjects) was 37.6% and 59.57% at age 1-5 years, 46.9% and 75% at age 6-10 years, 54.9% and 79.45% at age 11-15, 59.01% and 83.33% at age 20-30 years, 66.6% and 60.52% at age 31-40 years, 73.46% and 63.88% at age 41-50 years and 75.75% and 60% at age 51-60 years with mean titer of anti-CagA antibody of 75.94, 63.32, 57.11, 52.06, 23.62, 21.52 and 21.80 Uarb/mL, respectively. There was significant difference between mean serum anti-CagA antibody in age subgroups (P < 0.001).
CONCLUSION: These results showed that anti-H pylori and anti-CagA antibodies were common in the children and adults. The H pylori-specific antibodies influenced by age and sex of subjects. Moreover, it seems that males are more susceptible to infection with CagA(+) strains compared to females. The seroprevalence of anti-CagA antibody was increased with age, up to 30 years and then decreased. It was also found that the magnitude of the IgG response to CagA decreased with advanced age.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17589930      PMCID: PMC4172621          DOI: 10.3748/wjg.v13.i22.3117

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  34 in total

1.  Helicobacter pylori endemic and gastric disease.

Authors:  Farideh Siavoshi; Reza Malekzadeh; Mohammad Daneshmand; Hassan Ashktorab
Journal:  Dig Dis Sci       Date:  2005-11       Impact factor: 3.199

2.  Specific serum immunoglobulin G response to urease and CagA antigens of Helicobacter pylori in infected children and adults in a country with high prevalence of infection.

Authors:  Javier Torres; Margarita Camorlinga-Ponce; Guillermo Perez-Perez; Leopoldo Muñoz; Onofre Muñoz
Journal:  Clin Diagn Lab Immunol       Date:  2002-01

3.  Helicobacter pylori prevalence and CagA status among children in two counties of China with high and low risks of gastric cancer.

Authors:  W C You; L Zhang; K F Pan; J Jiang; Y S Chang; G I Perez-Perez; W D Liu; J L MA; M H Gail; M J Blaser; J F Fraumeni; G W Xu
Journal:  Ann Epidemiol       Date:  2001-11       Impact factor: 3.797

4.  Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains.

Authors:  G I Perez-Perez; A Salomaa; T U Kosunen; B Daverman; H Rautelin; A Aromaa; P Knekt; M J Blaser
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

5.  Helicobacter pylori anti-CagA antibodies: prevalence in symptomatic and asymptomatic subjects in Turkey.

Authors:  M Fatih Abasiyanik; Ersan Sander; Barik A Salih
Journal:  Can J Gastroenterol       Date:  2002-08       Impact factor: 3.522

6.  Serum Helicobacter pylori IgG and IgA levels in patients with gastric cancer.

Authors:  C Atalay; G Atalay; M Altinok
Journal:  Neoplasma       Date:  2003       Impact factor: 2.575

7.  Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease.

Authors:  Angelo Locatelli; Wilson Roberto Catapani; Claudio Rufino Gomes; Claudilene Battistin Paula Silva; Jaques Waisberg
Journal:  World J Gastroenterol       Date:  2004-10-15       Impact factor: 5.742

8.  A population based study of Helicobacter pylori infection in a European country: the San Marino Study. Relations with gastrointestinal diseases.

Authors:  G Gasbarrini; S Pretolani; F Bonvicini; M R Gatto; E Tonelli; F Mégraud; K Mayo; G Ghironzi; G Giulianelli; M Grassi
Journal:  Gut       Date:  1995-06       Impact factor: 23.059

9.  Transient and persistent Helicobacter pylori colonization in Native American children.

Authors:  Guillermo I Pérez-Pérez; R Bradley Sack; Raymond Reid; Mathuram Santosham; Janne Croll; Martin J Blaser
Journal:  J Clin Microbiol       Date:  2003-06       Impact factor: 5.948

10.  Seroprevalence of Helicobacter pylori in Chile: vegetables may serve as one route of transmission.

Authors:  R J Hopkins; P A Vial; C Ferreccio; J Ovalle; P Prado; V Sotomayor; R G Russell; S S Wasserman; J G Morris
Journal:  J Infect Dis       Date:  1993-07       Impact factor: 5.226

View more
  19 in total

Review 1.  Review of Helicobacter pylori infection and chronic renal failure.

Authors:  Mitsushige Sugimoto; Yoshio Yamaoka
Journal:  Ther Apher Dial       Date:  2010-08-31       Impact factor: 1.762

2.  cagA and vacA status and influence of Helicobacter pylori infection on serum oxidative DNA damage in Iranian patients with peptic ulcer disease.

Authors:  Z Khodaii; S M H Ghaderian; R Akbarzadeh Najar; H Nejati; A S Tabatabaei Panah
Journal:  Ir J Med Sci       Date:  2010-08-20       Impact factor: 1.568

3.  Frequency of Helicobacter pylori and cytotoxine associated gene A antibodies in patients with cardiac syndrome X.

Authors:  Yousef Rasmi; Mir-Hossein Seyyed-Mohammadzad
Journal:  J Cardiovasc Dis Res       Date:  2012-01

4.  Higher serum levels of rheumatoid factor and anti-nuclear antibodies in helicobacter pylori-infected peptic ulcer patients.

Authors:  Abdollah Jafarzadeh; Maryam Nemati; Mohammad Taghi Rezayati; Mansooreh Nabizadeh; Medhi Ebrahimi
Journal:  Oman Med J       Date:  2013-07

5.  Diversity of Helicobacter Pylori cagA and vacA Genes and Its Relationship with Clinical Outcomes in Azerbaijan, Iran.

Authors:  Reza Ghotaslou; Morteza Milani; Mohammad Taghi Akhi; Mohammad Reza Nahaei; Alka Hasani; Mohammad Saeid Hejazi; Mohammad Meshkini
Journal:  Adv Pharm Bull       Date:  2013-02-07

6.  Analysis of Helicobacter pylori genotypes in Afghani and Iranian isolates.

Authors:  Hossein Dabiri; Mehdi Bolfion; Akbar Mirsalehian; Maryam Rezadehbashi; Fereshteh Jafari; Leila Shokrzadeh; Navid Sahebekhtiari; Homayon Zojaji; Yoshio Yamaoka; Darioush Mirsattari; Mohammad Reza Zali
Journal:  Pol J Microbiol       Date:  2010

Review 7.  Epidemiology of Helicobacter pylori infection among the healthy population in Iran and countries of the Eastern Mediterranean Region: a systematic review of prevalence and risk factors.

Authors:  Ahad Eshraghian
Journal:  World J Gastroenterol       Date:  2014-12-14       Impact factor: 5.742

Review 8.  Helicobacter pylori Infection in the general population: A Middle Eastern perspective.

Authors:  Hossein Khedmat; Reza Karbasi-Afshar; Shahram Agah; Saeed Taheri
Journal:  Caspian J Intern Med       Date:  2013

9.  Distribution of Helicobacter pylori cagA, cagE, oipA and vacA in different major ethnic groups in Tehran, Iran.

Authors:  Hossein Dabiri; Parviz Maleknejad; Yoshio Yamaoka; Mohammad M Feizabadi; Fereshteh Jafari; Maryam Rezadehbashi; Farrokh A Nakhjavani; Akbar Mirsalehian; Mohammad R Zali
Journal:  J Gastroenterol Hepatol       Date:  2009-08       Impact factor: 4.029

10.  Serum levels of high-sensitivity C-reactive protein (hs-CRP)in Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.

Authors:  A Jafarzadeh; G H Hassanshahi; M Nemati
Journal:  Dig Dis Sci       Date:  2009-12       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.